Empagliflozin 10 MG
MEDiaN2018
Phase 3 small_molecule terminated
Quick answer
Empagliflozin 10 MG for Diabetic Nephropathies is a Phase 3 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Diabetic Nephropathies
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated